Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation

Abstract Background Novel circulating biomarkers may help in understanding the underlying mechanisms of atrial fibrillation (AF), a challenge for AF management and prevention of cardiovascular (CV) events. Whether glycosylation affects the prognostic value of N-terminal pro-B type natriuretic peptid...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lidia Staszewsky, Jennifer M. T. A. Meessen, Deborah Novelli, Ursula-Henrike Wienhues-Thelen, Marcello Disertori, Aldo P. Maggioni, Serge Masson, Gianni Tognoni, Maria Grazia Franzosi, Donata Lucci, Roberto Latini
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Atrial fibrillation, biomarkers
Brain natriuretic peptides
Recurrence
Cardiovascular hospitalization
Diseases of the circulatory (Cardiovascular) system
RC666-701
Accès en ligne:https://doaj.org/article/15ba99606609469697a5b64268aac08d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/15ba99606609469697a5b64268aac08d

Documents similaires